Keratoconjunctivitis Sicca: all 797 studies

Page 3 of 8. Open to participants first (56), then studies with results posted, then the rest; newest registration first within each.

• Safety and Efficacy of rhNGF Eye Drops at Different Doses in Patients With Dry EyeCompletedNCT02101281Phase 2Results posted
• Laser Therapy to Treat the Dry Mouth of Sjogren's SyndromeCompletedNCT02066896Not applicableResults posted
• Safety and Efficacy Study of R932348 Ophthalmic Solution in Chronic Ocular Graft Versus Host Disease Patients(DROPS-2)CompletedNCT02040623Phase 2Results posted
• A Study of Sodium Carboxymethylcellulose for Post Cataract Surgery Dry Eye SymptomsCompletedNCT02028754Phase 4Results posted
• Efficacy and Safety of T2762 and Vismed® in Dry Eye SyndromeCompletedNCT02023268Phase 3Results posted
• Phase 2 Study of a New Ophthalmic Formulation of Cyclosporine (Restasis® X) in Patients With Dry Eye DiseaseTerminatedNCT02013791Phase 2Results posted
• Clinical Outcomes Following Treatment With Systane® Balance in Dry Eye SubjectsCompletedNCT01967147Not applicableResults posted
• To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis SiccaCompletedNCT01900249Phase 2Results posted
• A Study to Determine the Prevalence of Inflammatory Dry Eye Disease in Patients Prior to Cataract RemovalCompletedNCT01882413Results posted
• Clinical Evaluation of Systane® ULTRA Compared to OPTIVE® in Ocular Surface StainingCompletedNCT01863368Not applicableResults posted
• An Observational Study of Dry Eye Prior to Laser-Assisted in Situ Keratomileusis (LASIK) TherapyCompletedNCT01854905Results posted
• Efficacy and Safety Study of FID 119515ACompletedNCT01833117Not applicableResults posted
• Impairment of Reading Ability in Dry Eye PatientsCompletedNCT01826812Results posted
• Lotemax® Gel 0.5% and Restasis 0.05% in Participants With Mild or Moderate Keratoconjunctivitis Sicca (Dry Eye Disease)CompletedNCT01817582Phase 2Results posted
• Effects of Dry Eye Treatments on the Ocular SurfaceCompletedNCT01797822Phase 4Results posted
• A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry EyeCompletedNCT01743729Phase 3Results posted
• SYSTANE® Family - Meibomian DeficiencyCompletedNCT01733745Not applicableResults posted
• SYSTANE® BALANCE Symptoms (OSDI) & Inflammatory BiomarkersCompletedNCT01733732Not applicableResults posted
• The Effect of SYSTANE® BALANCE on Tear Film Break Up Time in Dry Eye SubjectsCompletedNCT01718028Not applicableResults posted
• An Observational Study of OPTIVE PLUS® for the Treatment of Dry Eye DiseaseCompletedNCT01711424Results posted
• Evaluation of SYSTANE® BALANCE in Dry Eye Subjects With Lipid DeficiencyCompletedNCT01688726Not applicableResults posted
• Safety and Efficacy of Punctal Plug Insertion in Patients With Dry EyeCompletedNCT01684436Phase 4Results posted
• Pilot Study on the Use of Artificial Tears to Treat Dry Eye in Glaucoma PatientsCompletedNCT01682460Phase 4Results posted
• A Study to Compare the Safety and Efficacy of A New Eye Drop Formulation With OPTIVE™ in Subjects With Dry Eye DiseaseCompletedNCT01664949Phase 3Results posted
• Confirmatory Study of OPC-12759 Ophthalmic SolutionCompletedNCT01660256Phase 3Results posted
• Safety Study of Lifitegrast to Treat Dry EyeCompletedNCT01636206Phase 3Results posted
• Clinical Evaluation of a Daily Disposable Contact Lens in Symptomatic Weekly/Monthly Lens WearersCompletedNCT01614600Not applicableResults posted
• Comparison of the Efficacy and Safety of T2750 and Vismed® in the Treatment of Moderate to Severe Dry Eye SyndromeCompletedNCT01568593Phase 3Results posted
• Efficacy and Safety of PRO-148 Ophthalmic Solution Versus SYSTANE® in the Treatment of Patients With Dry Eye SyndromeCompletedNCT01541891Phase 2Results posted
• Randomized Controlled Trial of Long-term Treatment Effectiveness for Meibomian Gland Dysfunction (MGD) and Dry EyeCompletedNCT01521507Not applicableResults posted
• Safety, Efficacy, and Acceptability Study of an Eye Drop Formulation in Subjects With Dry Eye DiseaseCompletedNCT01459588Phase 3Results posted
• Prevalence of Dry Eyes in Diabetics Compared to Non DiabeticsTerminatedNCT01450787Results posted
• Safety and Efficacy Study of SAR 1118 to Treat Dry Eye Conducted in a Controlled Adverse Environment (CAE) (OPUS-1)CompletedNCT01421498Phase 3Results posted
• Comparative Study of Thymosin Beta 4 Eye Drops vs. Vehicle in the Treatment of Severe Dry EyeCompletedNCT01393132Phase 2Results posted
• Safety and Efficacy of Thymosin Beta 4 Ophthalmic Solution in Patients With Dry EyeCompletedNCT01387347Phase 2Results posted
• Sodium Hyaluronate Ophthalmic Solution, 0.18% for Treatment of Dry Eye SyndromeCompletedNCT01382225Phase 3Results posted
• Evaluation of the Effect of Repeated Usage on the Tear Film Characteristics of an Investigational Eye Drop in Dry Eye SufferersCompletedNCT01339936Phase 2/3Results posted
• Study of Two Formulations of Cyclosporine Ophthalmic Emulsion in Healthy Volunteers and in Patients With Dry EyeCompletedNCT01319773Phase 1Results posted
• RPS InflammaDry Detector™ to Determine MMP-9 Levels in TearsCompletedNCT01313351Results posted
• Safety and Efficacy Study of New Eye Drop Formulations With Refresh Tears® in Patients With Dry Eye DiseaseCompletedNCT01294384Phase 3Results posted
• Evaluation of Anti-Inflammatory Treatment in Dry Eye PatientsCompletedNCT01276223Phase 2Results posted
• The Effects of a Single Intravenous Administration of Secukinumab (AIN457) or Canakinumab (ACZ885) in Dry Eye PatientsCompletedNCT01250171Phase 2Results posted
• Phase III Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry EyeCompletedNCT01240382Phase 3Results posted
• Trial of CF101 to Treat Patients With Dry Eye DiseaseCompletedNCT01235234Phase 3Results posted
• A Dose Ranging Study to Evaluate Safety and Efficacy of Bromfenac Ophthalmic Solution in Dry Eye DiseaseCompletedNCT01212471Phase 3Results posted
• Late Phase II Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry EyeCompletedNCT01189032Phase 2Results posted
• Study to Assess the Safety and Efficacy of BOL-303242-X Ophthalmic Suspension in Dry Eye SyndromeCompletedNCT01163643Phase 2Results posted
• Effects of Cataract Extraction Surgery and Limbal Relaxing Incision on Corneal Sensation and Dry EyeCompletedNCT01161771Results posted
• A Phase II, Dose Ranging Study Of CP-690,550 Eye Drops In Patients With Dry Eye DiseaseCompletedNCT01135511Phase 2Results posted
• Non-invasive Tear Film Dynamic Measurements in Normal, MGD and ADDE Subjects After Saline InstillationCompletedNCT01128049Not applicableResults posted
• Oral Omega-3 Fatty Acids in the Treatment of Dry Eye SyndromeCompletedNCT01107964Not applicableResults posted
• Dry Eye Assessment and Management: Feasibility StudyCompletedNCT01102257Phase 2/3Results posted
• Pilot Study of a Homeopathic Therapy in Combination With Cyclosporin (Restasis) in the Treatment of Dry Eye DiseaseTerminatedNCT01072526Phase 2Results posted
• The Effect of a New Emulsion in Dry Eye Patients on Tear Layer Aberrometry, Contrast Sensitivity, and Reading AbilityCompletedNCT01013077Not applicableResults posted
• Safety and Efficacy of Two Artificial Tears in Dry Eye SubjectsCompletedNCT01010282Not applicableResults posted
• Safety and Efficacy of Carboxymethylcellulose for Ocular Surface Integrity in Symptomatic Dry EyeCompletedNCT00987727Phase 4Results posted
• Acupuncture for Dry Eye SyndromeCompletedNCT00969280Phase 3Results posted
• Study to Compare the Efficacy and Safety of Two Non-Preserved Artificial Tears for the Treatment of Dry Eye Signs and SymptomsCompletedNCT00938704Phase 4Results posted
• Safety and Tolerability of Artificial Tears in Dry Eye SubjectsCompletedNCT00932477Not applicableResults posted
• A Study Evaluating the Efficacy of SAR 1118 (0.1%, 1.0%, 5.0%) Ophthalmic Solution in Subjects With Dry Eye Conducted in a Controlled Adverse Environment (CAE)CompletedNCT00926185Phase 2Results posted
• Confirmatory Study of OPC-12759 Ophthalmic SuspensionCompletedNCT00885079Phase 3Results posted
• TearLab Core Validation Study to Establish Referent Values for Dry Eye DiseaseCompletedNCT00848198Results posted
• Treatment of Meibomian Gland Dysfunction and Evaporative Dry EyeCompletedNCT00832130Not applicableResults posted
• Long Term Administration Study of OPC-12759 Ophthalmic SuspensionCompletedNCT00818324Phase 3Results posted
• A Prospective, Randomized, Placebo and Active Comparator Controlled Study of CP-690,550 in Subjects With Dry Eye.CompletedNCT00784719Phase 1/2Results posted
• Performance and Acceptance of Optive Versus Hylocomod Eyedrops in Patients With Dry Eye SymptomsCompletedNCT00761202Phase 4Results posted
• Safety and Efficacy of an Ophthalmic Solution in Dry Eye DiseaseCompletedNCT00758784Phase 2Results posted
• Efficacy Study of Cyclosporine Ophthalmic Emulsion in Patients With Dry Eye DiseaseCompletedNCT00717418Results posted
• Tear Film Break-up Time After Instillation of Artificial TearsCompletedNCT00681265Not applicableResults posted
• Efficacy Study of Ecabet Ophthalmic Solution in Dry Eye DiseaseCompletedNCT00667004Phase 2Results posted
• Evaluation of Blink Tears and Systane Concomitant With Restasis for the Treatment of Dry Eye SymptomsCompletedNCT00565669Not applicableResults posted
• The Prophylactic Use of Topical Cyclosporine A 0.05% to Prevent Graft Versus Host Disease Related Dry EyeTerminatedNCT00553735Phase 4Results posted
• Safety and Efficacy of an Artificial Tear for the Treatment of Dry EyeCompletedNCT00514852Not applicableResults posted
• Late Phase 2 Study of OPC-12759 Ophthalmic SuspensionCompletedNCT00475319Phase 2Results posted
• Safety and Efficacy Study of CF101 to Treat Keratoconjunctivitis SiccaCompletedNCT00349466Phase 2Results posted
• Dose-response Study of OPC-12759 Ophthalmic SuspensionCompletedNCT00234078Phase 2Results posted
• Tolerability and Efficacy Study of Reinnerva/Lubristil+G vs VismedCompletedNCT07422259Not applicable
• Medical vs Acupuncture for Dry EyeCompletedNCT07185854Not applicable
• Vizol S DIGI EYE Efficacy and Safety Study in Patients With Dry EyeCompletedNCT07050446Phase 3
• Dry Eye Disease and Retinal Nerve Fiber Layer Thickness in Chronic SmokersCompletedNCT07028736
• DOMPE -MT Neurotrophic KeratitisActive, not recruitingNCT06947850Phase 4
• Efficacy of Warm Compress Therapy in Enhancing Tear Film Quality and Reducing Postoperative DESActive, not recruitingNCT06914232Not applicable
• Comparing Effect of Hylorunic Acid and Lipid-coated Carbomer Gel on Dry Eyes After Phacoemulsification in DPActive, not recruitingNCT06913556Not applicable
• Comparison Of Blue Light Filter Feature and Blue Blocking Lenses in Digital Device Users With Dry Eye PatientsActive, not recruitingNCT06913504Not applicable
• Effect of Obesity on Tear Film and Ocular Health Among Diabetic PatientsActive, not recruitingNCT06913452
• Comparing Effect of Hyaluronic Acid and Lipid Coated Carbomer Gel on Dry Eyes After Phacoemulsification in DPActive, not recruitingNCT06901895Not applicable
• Once-daily Fluorometholone vs Twice-daily Cyclosporine in Dry Eye DiseaseCompletedNCT06876116Phase 4
• Efficacy of 0.38% and 0.18% Sodium Hyaluronate Ocular Lubricants for Dry Eye in Adult Gazan ParticipantsCompletedNCT06851364Phase 2
• The Effect of 0.05% CsA Eye Drops on Diabetic Patients with Dry Eye DiseaseCompletedNCT06824844Phase 4
• AI Chatbot-Based Learning on Dry Eye and Eye Strain KnowledgeCompletedNCT06785155Not applicable
• Dry Eye and Asthenopia Treatment Effect Evaluation.CompletedNCT06763822Not applicable
• Efficacy of Pilocarpine As a Secretagogue Versus Artificial Tears for the Treatment of Dry EyeCompletedNCT06752278Not applicable
• The Effect of Omega 3 Supplements Comparison With Warm Compression in Patients With Dry Eye DiseaseActive, not recruitingNCT06748768
• Treatment Effect of Intense Pulsed Light and Thermal Pulsation Therapy on Meibomian Gland Dysfunction-associated Dry Eye Disease: a Randomized TrialCompletedNCT06745089Not applicable
• Dietary Supplementation on Tear Secretion and Inflammation in DESCompletedNCT06738446Not applicable
• Post-marketing Study Focused on Evaluating I+Med's DayDrop for Improving Signs and Symptoms of Mild/Moderate Dry EyeCompletedNCT06731725Not applicable
• Hydroxypropyl-methylcellulose and GlicoPro® Eyedrops in the Treatment of Dry Eye Disease: Clinical StudyCompletedNCT06726525Phase 4
• Acupoint Therapy Device for Dry EyeCompletedNCT06720428Not applicable
• Laser Acupuncture for Dry Eye Disease Due to Visual Display Terminal UseCompletedNCT06688630Not applicable
• The Beijing Adult Dry Eye Cohort StudyActive, not recruitingNCT06621446

← Keratoconjunctivitis Sicca overview